Company intelligence / Profile preview

Wellthy Therapeutics

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~61
Development stage: Other

Overview

Wellthy Therapeutics' digital therapeutics platform and programs have demonstrated strong real-world outcomes: 85% reduction in pain (rheumatoid arthritis), 90% medication adherence uplift, 1.1% absolute HbA1c reduction, 98% successful pregnancy delivery, 61% cholesterol reduction, 83% improvement in quality of life, and over 79% BMI decrease in relevant cohorts.

Therapeutic areas: ImmunologyCardiovascularEndocrinologyWomen's HealthPsychiatry
Modalities: Non-pharmacological therapyDigital therapeutic (custom)
Industry: Digital Health Medical Devices

Partnerships

Insurerspharmaceutical and medical device companieshealth systemsgovernments

Beyond the preview

Go deeper on Wellthy Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wellthy Therapeutics.

Explore the full profile